CRA was retained to assess consumer claims that “Buy One Get One” or “Buy One Get Two” sales practices improperly induce consumer purchases with false and misleading product price information and false time-limits for nutritional products. In particular, CRA assessed Plaintiffs’ claim that such sales practices mislead consumers into believing that they are receiving an extra product as a “free gift.”
Life Sciences Litigation Insights: March 2022
Carl Washington et al. v. CVS Pharmacy Inc., Northern District of California, No. 4:15-vc-19-03504 On June 23, 2021 a federal jury in northern California...